Inferring the true number of SARS-CoV-2 infections in Japan

In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2022-11, Vol.28 (11), p.1519-1522
Main Authors: McKenzie, Lauren, Shoukat, Affan, Wong, Kai On, Itahashi, Koju, Yasuda, Eiji, Demarsh, Alex, Khan, Kamran
Format: Article
Language:English
Subjects:
Adult
Case counts
COVID-19 - epidemiology
Humans
Infection fatality rates
Japan - epidemiology
Original
Pandemics
SARS-CoV-2
Seroepidemiologic Studies
Under-ascertainment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities. We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions. We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05–4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan. We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures.
ISSN:1341-321X
1437-7780
DOI:10.1016/j.jiac.2022.08.002